Pharyngitis Treatment Market Report 2026

Pharyngitis Treatment Market Overview

• Pharyngitis Treatment market size has reached to $2.37 billion in 2025 • Expected to grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: Increasing Cases Of Influenza Drive Pharyngitis Treatment Market • Market Trend: Advancements In Pharyngitis Treatment Focus On Oral Monotherapy For Enhanced Patient Compliance • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharyngitis Treatment Market?

Pharyngitis treatment refers to the management and care provided to individuals experiencing inflammation of the mucous membranes of the oropharynx, commonly known as the throat. Pharyngitis can be caused by a variety of reasons, including bacterial or viral infections, allergies, trauma, malignancy, reflux, and some poisons. The main drug class types of pharyngitis treatment are beta-lactams, macrolides, cephalosporins, fluoroquinolones, tetracycline and others. Beta-lactams are a class of antibiotics that contain a beta-lactam ring in their chemical structure. The various source of infection includes viral and bacterial. The various modes of delivery include oral, intravenous, intramuscular and others that are used by various end-users such as hospitals, homecare, specialty centers and others.

What Is The Pharyngitis Treatment Market Growth Forecast?

The pharyngitis treatment market size is expected to see strong growth in the next few years. It will grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing focus on precision infection management, rising demand for resistance-aware therapies, expansion of digital diagnosis platforms, growing investments in novel antibiotic development, increasing adoption of home-based treatment models. Major trends in the forecast period include increasing development of targeted antibiotic therapies, rising adoption of rapid diagnostic support tools, growing use of combination drug regimens, expansion of telemedicine-linked treatment models, enhanced focus on antimicrobial stewardship.

Global Pharyngitis Treatment Market Segmentation

1) By Drug Class: Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes 2) By Source Of Infection: Viral, Bacterial 3) By Modes Of Delivery: Oral, Intravenous, Intramuscular, Other Modes Of Delivery 4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users Subsegments: 1) By Beta Lactams: Penicillins, Amoxicillin, Ampicillin 2) By Macrolides: Erythromycin, Azithromycin, Clarithromycin 3) By Cephalosporins: Cefuroxime, Ceftriaxone, Cefdinir 4) By Fluoroquinolones: Ciprofloxacin, Levofloxacin, Moxifloxacin 5) By Tetracycline: Doxycycline, Minocycline, Tetracycline 6) By Other Drug Classes: Clindamycin, Sulfonamides, Carbapenems

What Is The Driver Of The Pharyngitis Treatment Market?

The growing incidence of influenza is expected to propel the growth of the pharyngitis treatment market going forward. Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. Pharyngitis treatment is primarily used to treat influenza and is helpful for the flu by relieving the symptoms, which are inflammation or irritation, and this treatment focused on relieving allergies and preventing complications such as pneumonia and bronchitis. For instance, in July 2023, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency. In the 2022/2023 influenza season in the EU/EEA, the percentage of positive influenza specimens reached 28% from week 5 to week 12 of 2023. Therefore, the growing incidence is driving the growth of the pharyngitis treatment industry.

Key Players In The Global Pharyngitis Treatment Market

Major companies operating in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals plc, Lupin Limited, Aurobindo Pharma Limited, Sandoz Group AG, Alkem Laboratories Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd.

Global Pharyngitis Treatment Market Trends and Insights

Major companies operating in the pharyngitis treatment market are focusing on developing innovative products such as oral monotherapy to enhance patient compliance and provide effective, convenient treatment options. Oral monotherapy refers to the use of a single drug or medication administered orally (by mouth) to treat a specific condition or disease. It involves the administration of just one therapeutic agent as opposed to a combination of multiple treatments to achieve the desired therapeutic effect. For instance, in December 2023, Novartis AG, a Switzerland-based pharmaceutical corporation, received FDA approval for Fabhalta (iptacopan), establishing it as the first oral monotherapy for adults with paroxysmal nocturnal hemoglobinuria (PNH). This milestone, achieved on [date], represents a significant advancement by offering a new treatment option that enhances hemoglobin levels, eliminating the need for blood transfusions.

What Are Latest Mergers And Acquisitions In The Pharyngitis Treatment Market?

In January 2024, iNova Pharmaceuticals (Australia) Pty Limited, an Australia-based pharmaceutical company, acquired Mundipharma’s Consumer Health business for an undisclosed amount. With this acquisition, iNova aimed to expand its consumer healthcare portfolio and strengthen its presence in global over-the-counter (OTC) markets, including sore-throat and pharyngitis treatments. Mundipharma is a UK-based pharmaceutical company that specializes in providing consumer healthcare products, including OTC remedies for sore throat, oral care, and other wellness categories.

Regional Outlook

North America was the largest region in the pharyngitis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharyngitis Treatment Market?

The pharyngitis treatment market consists of sales of antibiotics, antiviral drugs and antifungal medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharyngitis Treatment Market Report 2026?

The pharyngitis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharyngitis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.